Hy-Cortisone Injection 100mg is primarily indicated in conditions like Adrenal insufficiency, Anaphylactic reactions, Apthous ulcers, Atopic eczema, Collagen disease, Congenital adrenal hyperplasia, Contact allergic dermatitis, Discoid eczema, Flexural psoriasis, Graft rejection, Hypercalcaemia, Infantile eczema, Inflammation, Irritant dermatitis, Itching, Joint inflammation, Perineal trauma, Seborrheic dermatitis, Shock, Soft tissue inflammation, Status asthmaticus, Ulcerative protocolitis, and can also be given in adjunctive therapy as an alternative drug of choice in Anaphylactic shock, Insect bites, Otitis externa, Sunburn, Ulcerative colitis.
Hy-Cortisone Injection 100mg is contraindicated in conditions like Ulcers, Systemic infections, Hypersensitivity.
The severe or irreversible adverse effects of Hy-Cortisone Injection 100mg, which give rise to further complications include Convulsions, Gi bleeding, Telangiectasia, Striae, Glvisual function, Tendon rupture, Intestinal perforation, Opportunistic infections, Addisonian crises, Adrenal atrophy, Increased IOP (intraocular pressure), Subcutaneous atrophy.Hy-Cortisone Injection 100mg produces potentially life-threatening effects which include Anaphylactoid reactions, Addisonian crises, CHF, Opportunistic infections, Acute pancreatitis, GI hemorrhage, which are responsible for the discontinuation of Hy-Cortisone Injection 100mg therapy.The signs and symptoms that are produced after the acute overdosage of Hy-Cortisone Injection 100mg include hypomagnesaemia, Hyperkalemia, Adrenal suppression.aucoma, Cataract, Pancreatitis, Hypersensitivity reactions, Osteoporosis, Psychosis, Increased intracranial pressure, Growth retardation, Glucose intolerance, Epidermal thinning, Vertebral fractures, Avascular necrosis, Papilloedema, Opthalmic fungal or viral disease, Dendritic corneal ulcers, Thromboembolic disorder, Long bone fractures, Hypokalemic alkalosis,
Hy-Cortisone Injection 100mg should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy.